Personnel

Viral disease-focused company reports resignation of VP of medical affairs

Published in Hepatitis Weekly, March 21st, 2005

SciClone Pharmaceuticals, Inc. (SCLN) announced that Eduardo B. Martins, MD, D.Phil, vice president of medical affairs, has resigned in order to accept a position with another biopharmaceutical company.

Alfred R. Rudolph, MD, chief operating o0fficer of SciClone, said, "Eduardo played an integral role in advancing the development of our lead product Zadaxin, most notably with respect to our U.S. phase 3 hepatitis C clinical trials."

SciClone has engaged an executive recruiter to identify candidates with experience developing products for the treatment of viral and infectious diseases or cancer.

Until a replacement has been...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2005-03-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry